SIC
KURA icon

SJS Investment Consulting’s Kura Oncology KURA Stock Holding History

SJS Investment Consulting’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.98K Buy
454
+406
+846% +$3.83K ﹤0.01% 1387
2026
Q1 		$391 Sell
48
-91
-65% -$782 ﹤0.01% 1824
2025
Q4 		$1.45K Buy
+139
New +$1.46K ﹤0.01% 1198

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
OAM
OP Asset Management Helsinki $9.38B AUM 42.35% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return

SJS Investment Consulting's KURA Position: Q2 2026 in Review

SJS Investment Consulting increased its Kura Oncology (KURA) stake by 846% in Q2 2026, buying an estimated $3.83K and bringing the position to 454 shares worth $4.98K. The position accounts for ﹤0.01% of the portfolio, ranked #1387.

SJS Investment Consulting first reported a position in KURA in Q4 2025 and has held it in 3 quarters since. 77 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • SJS Investment Consulting held 454 shares of Kura Oncology worth $4.98K as of Q2 2026.
  • SJS Investment Consulting bought 406 Kura Oncology shares in Q2 2026, an estimated $3.83K.
  • Kura Oncology made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1387 holding.
  • SJS Investment Consulting first reported a position in Kura Oncology in Q4 2025 and has held it in 3 quarters since.
  • 77 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.